FDA inspection
Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant): FDA inspection ending Mar 14, 2025
FDA inspection 1261674 · No Action Indicated (NAI) · Wenzhou
Key facts
| Inspection ID | 1261674 |
|---|---|
| Firm | Zhejiang Kangle Pharmaceutical Co., Ltd (Binhai Plant) |
| FEI number | 3010728912 |
| Address | Binhai Industrial Park, No. 555 The 8th Binhai Rd.; Longwan District |
| City | Wenzhou |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Mar 14, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data